Germany’s Merck buys Silence Therapeutics for $1.3 billion
German drugmaker Merck KGaA said on Monday it will acquire therapy developer Silence Therapeutics in an all-cash deal for about $1.3 billion.
German drugmaker Merck KGaA said on Monday it will acquire therapy developer Silence Therapeutics in an all-cash deal for about $1.3 billion.